Healthcare experts suggest that India could increase its share in the global clinical trials market by learning from countries like China and Australia. India currently holds an 8% share, compared to China’s 29%. Experts emphasize improving regulatory speed, offering incentives, and raising patient awareness for trials. India’s clinical trials market is growing, with projected revenues exceeding $2 billion by 2030.